tiprankstipranks
BioCryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market
BCRX
BioCryst
RESEARCH TOOLSreports
Want to see BCRX full AI Analyst Report?

BioCryst (BCRX) Balance Sheet

2,732 Followers

BioCryst Balance Sheet

BioCryst's total assets for Q1 2026 were $465.05M, a decrease of -9.55% from the previous quarter. BCRX total liabilities were $1.02B for the fiscal quarter, a 60.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 514.16M$ 490.42M$ 516.96M$ 550.00M$ 588.15M
Total Liabilities
$ 633.31M$ 966.35M$ 972.49M$ 844.60M$ 695.14M
Total Equity Gross Minority
$ -119.15M$ -475.93M$ -455.53M$ -294.60M$ -106.99M
Other Metrics
Currency in USD

BioCryst Debt to Assets